Efficacy and safety of GLP-1 receptor agonists in Parkinson’s disease- a systematic review
A recent study examines the use of GLP-1RAs in Parkinson's disease, finding no significant motor benefits but some improvement in quality of life.
CBD:THC Ratios Show Neuroprotection in Brain Injury Study – CED Clinic
Emerging research on CBD THC ratios for brain injury neuroprotection reveals promising preclinical mechanisms, though human clinical translation remains early-stage. Understanding cannabinoid synergy and realistic therapeutic expectations guides…
Cannabinoids and cognition in Parkinson’s disease: Insights from animal models and emerging clinical evidence.
Parkinson's disease (PD) is a progressive, multisystem neurodegenerative disorder characterized not only by motor impairments but also by a broad spectrum of...
The cannabidiol (CBD): Tetrahydrocanabinol (THC) concentration ratio is critical for neuroprotection and recovery following traumatic brain injury.
Preclinical research demonstrates that specific CBD THC ratio neuroprotection mechanisms outperform CBD isolate in traumatic brain injury models. This study supports the entourage effect hypothesis while highlighting the need for human clinical trials to…
Exploring the neuroprotective effects of phytocannabinoids on oxygen-glucose deprived neurons in an in vitro model of stroke.
Recent laboratory research on cannabinoids for stroke neuroprotection showed modest benefits from seven phytocannabinoids in protecting brain cells. While promising, these early findings require extensive additional research before clinical applications.
Cannabidiol Modulates Glutamate and Learning in Psychosis
A single dose of cannabidiol glutamate psychosis modulation reduced abnormal brain activity in people at clinical high risk for psychosis. CBD may normalize glutamate-related neurotransmission patterns contributing to psychosis risk. This supports…
Cannabis Brain Health and Aging: A Clinical Review – CED Clinic
Cannabis neuroprotection aging is an emerging area of clinical interest. Research highlights cannabinoids' potential benefits and risks for brain health in older adults. Understanding these effects is essential for safe clinical use in aging populations.
The cannabidiol (CBD): Tetrahydrocanabinol (THC) concentration ratio is critical for neuroprotection and recovery following traumatic brain injury.
An optimal cbd thc neuroprotection ratio is hypothesized to protect against neuropathological consequences following traumatic brain injury. This study compares different cbd thc ratios for neuroprotective effects. Understanding this ratio is critical…
CBD Gummies and Alzheimer’s: What the Evidence Shows for Cognitive and Behavioral Support
CBD gummies for dementia are gaining attention for their potential neuroprotective and anti-inflammatory effects. Current evidence suggests possible benefits for cognitive and behavioral symptoms in Alzheimer's disease. However, clinical data remain…
New Insights on Structural Brain Imaging in Cannabis and Tobacco Users
Structural brain imaging cannabis tobacco effects reveal important data on brain volume changes. This study highlights dose-dependent relationships and additive effects of concurrent use. Understanding these effects aids clinical discussions about…